Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A J Johnson
Risk Factors for Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With the Cyclin-Dependent Kinase Inhibitor, Flavopiridol
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
QuantitativeN-terminal Analysis of Fibrinogen-Fibrin-Related Antigen [FR Antigen] From Human Plasma
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Related publications
Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia
Turkish Journal of Haematology
Hematology
Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide
Clinical Journal of Oncology Nursing
Oncology
A Phase I Clinical Trial of FOLFIRI in Combination With the Pan-Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
The Cyclin-Dependent Kinase Inhibitor Flavopiridol (Alvocidib) Inhibits Metastasis of Human Osteosarcoma Cells
Oncotarget
Oncology
Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia
Oncology and Therapy
Oncology
Comment on Lipsky Et Al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
Haematologica
Hematology
Tumour Debulking and Reduction in Predicted Risk of Tumour Lysis Syndrome With Single-Agent Ibrutinib in Patients With Chronic Lymphocytic Leukaemia
British Journal of Haematology
Hematology
Bruton's Tyrosine Kinase Inhibitor Restrains WNT Signaling in Chronic Lymphocytic Leukemia
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
